Belgium· BE-AMP-SAM288881-00

RotaTeq

A rotavirus, pentavalent, lebend, abgeschwächt product containing human rotavirus, registered in Belgium by Merck Sharp & Dohme. The same ATC class is registered in 10 of our 19 countries.

ATC J07BH02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedRotaTeqATCJ07BH02REGISTER NO.BE-AMP-SAM288881-00PACKS LISTED8CHECKEDSeptember 26, 2026

Where it is registered

Rotavirus, pentavalent, lebend, abgeschwächt is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BH02 (rotavirus, pentavalent, lebend, abgeschwächt), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose

Rotavirus, pentavalent, lebend, abgeschwächt · ATC J07BH02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Rotavirus
Manufacturer
Merck Sharp & Dohme
Country
Belgium (BE)
ATC code
J07BH02
ATC class
Rotavirus, pentavalent, lebend, abgeschwächt
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 8

2 priced
  • be_apb
    2322436
    EUR 53.22
  • be_apb
    4280848
    EUR 53.22
  • be_apb
    0785840
  • be_apb
    7707268
  • be_apb
    3138443
  • be_apb
    7730724
  • be_apb
    7734957
  • be_apb
    4490991

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dd0f2c59-4321-49ec-804c-4272ada34056
GET /v1/drugs/dd0f2c59-4321-49ec-804c-4272ada34056?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "RotaTeq",
  "name_fr": "RotaTeq",
  "name_nl": "RotaTeq",
  "amp_code": "SAM288881-00",
  "strengths": null,
  "pack_count": 5,
  "substances": [
    "Human Rotavirus",
    "Sodium Dihydrogen Phosphate Monohydrate",
    "Sodium Hydroxide",
    "Sucrose",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Rota Virus, Pentavalent, Live, Reassorted",
  "authorisation_numbers": [
    "EU/1/06/348/001",
    "EU/1/06/348/002"
  ]
}

See everything about rotavirus, pentavalent, lebend, abgeschwächt.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.